Milestone Scientific (NYSE:MLSS) Stock Price Up 5.2% – Here’s Why

Milestone Scientific Inc. (NYSE:MLSS) traded up 5.2% on Thursday . The stock traded as high as $0.3550 and last traded at $0.3550. Approximately 244,115 shares were traded during mid-day trading, a decline of 79% from the average session volume of 1,140,437 shares. The stock had previously closed at $0.3375.

Milestone Scientific Trading Up 5.2%

The stock has a 50 day moving average of $0.36 and a 200-day moving average of $0.31. The stock has a market capitalization of $31.40 million, a P/E ratio of -5.07 and a beta of 1.05.

Institutional Trading of Milestone Scientific

An institutional investor recently raised its stake in Milestone Scientific stock. Raymond James Financial Inc. raised its holdings in shares of Milestone Scientific Inc. (NYSE:MLSS) by 416.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 62,000 shares of the company’s stock after purchasing an additional 50,000 shares during the quarter. Raymond James Financial Inc. owned 0.08% of Milestone Scientific worth $39,000 at the end of the most recent reporting period. Hedge funds and other institutional investors own 5.79% of the company’s stock.

About Milestone Scientific

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.